Ind-Swift Laboratories – Mohali

Ind-Swift Laboratories Ltd is a leading pharmaceutical company headquartered in Mohali, Punjab, with integrated API and formulations manufacturing capabilities. Ind-Swift is one of India’s top cephalosporin antibiotic manufacturers and has built a strong position in the global regulated generic pharmaceutical market. The company’s Mohali facility is a key operational base for research, regulatory affairs, and domestic sales management.

Ind-Swift’s product range includes cephalosporins, macrolides, fluoroquinolones, antifungals, and cardiovascular formulations. The company holds regulatory approvals from USFDA, MHRA, EUGMP, and other international agencies. Ind-Swift offers pharma franchise for its domestic branded portfolio and provides contract manufacturing services through its group companies.

Key Highlights

• Leading cephalosporin antibiotic manufacturer in India
• USFDA, MHRA, and EUGMP approved facilities
• Cephalosporins, macrolides, fluoroquinolones, and antifungals
• Integrated API and formulations manufacturing
• Pharma franchise and contract manufacturing available